There was an oversight regarding the acknowledgement of funding from the European Research Council, which was a contractual obligation for the funding. Professor Sukhi Shergill was funded by an ERC Consolidator Award.
No CrossRef data available.
Article contents
Clozapine in a patient with treatment-resistant schizophrenia and hypertrophic cardiomyopathy: a case report — ADDENDUM
Published online by Cambridge University Press: 13 June 2019
Abstract
An abstract is not available for this content. As you have access to this content, full HTML content is provided on this page. A PDF of this content is also available in through the ‘Save PDF’ action button.
- Type
- Addendum
- Information
- Creative Commons
This is an Open Access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives licence (http://creativecommons.org/licenses/by-ncnd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is unaltered and is properly cited. The written permission of Cambridge University Press must be obtained for commercial re-use or in order to create a derivative work.- Copyright
- Copyright © The Royal College of Psychiatrists 2019
References
Sanchez, AYA, Foster, JJ, Plymen, CM and Shergill, S. Clozapine in a patient with treatment-resistant schizophrenia and hypertrophic cardiomyopathy: a case report. BJPsych Open 2016; 2: 390–393.10.1192/bjpo.bp.116.003723Google Scholar
This addendum applies to the following article(s):
You have
Access
Open access
eLetters
No eLetters have been published for this article.